e-ISSN: Pending

Browse the failure-mode index

12,380 real negative results, null findings, and replication failures in Medicine. Search the index →

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record compiled from open scholarly databases; the abstract is shown in full only where the paper is openly licensed, otherwise a short excerpt under fair use. Classifications are automated and approximate.

Negative / Null Result ReportOpen accessMedicine

Effects of a whole-school relationships and sexual health intervention on non-competent sexual debut: cluster-randomised trial.

Ponsford R, Meiksin R, Sturgess J et al. · 2026 · Journal of epidemiology and community health

Background Relationships and sex education (RSE) impacts some sexual behaviours but could be strengthened by incorporating whole-school approaches (eg, building engagement, providing contraception). These can prevent pregnancies and…

View details →
Negative / Null Result ReportMedicine

Efficiency of Cinnamomum camphora var. linaloofera Fujita essential oil, MS-222, and linalool on anesthesia and transportation of spotted seabass (Lateolabrax maculatus).

Cao J, Guo M, Wang J et al. · 2025 · Fish physiology and biochemistry

Plant-based essential oils have been considered to be used as fish anesthetics and as suitable alternatives to synthetic anesthetics. In this study, we evaluated the effect of Cinnamomum camphora var. linaloofera Fujita essential oil…

View details →
Failed Experiment ReportMedicine

Insights into Alternaria in apple fruit causing mouldy core, external infection and mycotoxin production under retail and storage conditions.

Pavicich MA, Maldonado ML, Nguyen TN et al. · 2025 · International journal of food microbiology

Apple fruit is widely consumed worldwide, but fungal contamination in the postharvest stage presents a significant food safety concern. This study evaluates the production and accumulation of Alternaria mycotoxins, including alternariol…

View details →
Negative / Null Result ReportMedicine

Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA YOLK) administered by parenteral or mucosal routes against Brucella ovis in rams.

Moran MC, Tammone Santos A, Dominguez P et al. · 2025 · Veterinary immunology and immunopathology

Brucella ovis (B. ovis) is the etiological agent of ram-contagious epididymitis, the leading cause of reproductive disorders in flocks worldwide. Although the attenuated B. melitensis Rev.1 strain gives heterologous protection against this…

View details →
Negative / Null Result ReportOpen accessMedicine

Fungal vaccines: so needed, so feasible, and yet so far off.

Casadevall A · 2025 · The Journal of clinical investigation

Invasive fungal infections carry high morbidity and mortality, but there are no fungal vaccines. In this issue of the JCI, Okaa et al. report that endonuclease 2 (Eng2), an antigen shared by the Blastomyces, Histoplasma, and Coccidioides…

View details →
Negative / Null Result ReportOpen accessMedicine

Epigallocatechin gallate (EGCG) partially prevents elastase-induced mechanical and microstructural changes in the mouse ascending aorta in vitro.

Castro LA, Chen DE, O'Scannlain A et al. · 2026 · Journal of the mechanical behavior of biomedical materials

Elastic fibers are critical for proper mechanical function of large arteries such as the aorta. Fragmentation, degradation, or reduced amounts of elastic fibers are associated with aortic diseases such as stiffening-induced hypertension…

View details →
Negative / Null Result ReportMedicine

Influenza A(H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies: Insights from human airway epithelia and murine models.

Fage C, Loison S, Zwygart AC et al. · 2025 · Antiviral research

Influenza viruses pose a significant threat due to annual epidemics and pandemic potential. Resistance to current antivirals underscores the need for new drugs and strategies to prevent its emergence. We previously developed two novel…

View details →
Negative / Null Result ReportMedicine

Selective PI3Kγ inhibition attenuates chemotherapy-induced intestinal mucositis without compromising the anticancer properties of irinotecan.

Cajado AG, Lopes MH, Rangel GFP et al. · 2025 · European journal of pharmacology

Irinotecan-based anticancer therapy induces intestinal mucositis, increasing the risk of sepsis and patient death. The phosphoinositide 3-kinases (PI3K) are involved in cancer and inflammatory diseases, but their role in intestinal…

View details →
Negative / Null Result ReportOpen accessMedicine

Bisphosphonate Therapy and the Occurrence of the Hungry Bone Syndrome After Surgery for Primary Hyperparathyroidism.

Etemadi R, Mansouri A, Salehidoost R et al. · 2025 · International journal of endocrinology

Objective Hungry bone syndrome (HBS), marked by severe and persistent hypocalcemia, frequently occurs after parathyroidectomy for primary hyperparathyroidism (PHPT). Despite its prevalence, there is limited research on this complication.…

View details →
Negative / Null Result ReportMedicine

A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).

Watanabe S, Furuya N, Nakamura A et al. · 2024 · European journal of cancer (Oxford, England : 1990)

Introduction Treatment options for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) after EGFR-tyrosine kinase inhibitor (TKI) treatment failure are limited. An exploratory analysis of 26…

View details →
Negative / Null Result ReportMedicine

At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact.

Boess FG, Scelsi MA, Grimmer T et al. · 2024 · The journal of prevention of Alzheimer's disease

Background Monoclonal antibodies that target amyloid-beta and remove amyloid plaques can slow cognitive and functional decline in early Alzheimer's disease. Gantenerumab is a subcutaneously administered fully-human anti-amyloid-beta…

View details →
Negative / Null Result ReportOpen accessMedicine

Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.

Hanna GJ, Scarfo N, Shin KY et al. · 2026 · Clinical cancer research : an official journal of the American Association for Cancer Research

Purpose Glycogen synthase kinase 3β (GSK-3β) is a known therapeutic target in cancer. Aberrant nuclear GSK-3β (nGSK-3β) expression has been shown in some salivary gland cancers. Elraglusib is a small-molecule GSK-3β inhibitor with…

View details →
Negative / Null Result ReportMedicine

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary.

Finch L, Andres S, Iasonos A et al. · 2025 · International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Objective We sought to determine the safety and efficacy of the oral progesterone antagonist onapristone in combination with anastrozole in patients with recurrent progesterone receptor-positive adult-type granulosa cell tumor of the…

View details →
Negative / Null Result ReportOpen accessMedicine

ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial.

Kim EH, Carr WW, Assa'ad AH et al. · 2025 · The journal of allergy and clinical immunology. Global

Background Oral immunotherapy is an established approach to desensitize the immune system in the context of allergic disease; however, the only currently approved product is for peanut allergy. ADP101 is a novel, pharmaceutical-grade,…

View details →
Negative / Null Result ReportMedicine

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

Ozer BH, Cohen AL, Colman H et al. · 2026 · Neuro-oncology advances

Background Glioblastoma (GBM) has limited effective salvage therapy options. The combination of the Type 1B topoisomerase/HIF1α inhibitor topotecan and the tyrosine kinase inhibitor pazopanib has shown promise in solid tumors and may be…

View details →
Negative / Null Result ReportOpen accessMedicine

Persistent Hyperparathyroidism in Vitamin D-Dependent Rickets Type 2A Does Not Prevent Normalization of Hypophosphatemia or Healing of the Rickets.

Lodefalk M, Nilsson O · 2025 · Hormone research in paediatrics

Introduction Vitamin D-dependent rickets type 2A (VDDR2A) is a rare, autosomal recessive disorder caused by pathogenic variants of the VDR gene encoding the vitamin D receptor. It has been proposed to be a form of parathyroid hormone…

View details →
Negative / Null Result ReportOpen accessMedicine

A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor-Hair Serum for the Prevention of Chemotherapy-Induced Alopecia.

Mann K, Potluri P, Paul EE et al. · 2026 · Journal of cosmetic dermatology

Introduction Chemotherapy-induced alopecia (CIA) is known to have a significant psychological and quality of life impact. Although cold caps have been shown to prevent CIA, expense and extension of treatment durations are barriers for…

View details →
Negative / Null Result ReportOpen accessMedicine

Germination control by a hard seed coat: insights from a tropical legume.

Pereira GF, Sanches MC, De-Paula OC et al. · 2025 · Scientific reports

Classifying seed dormancy is an essential task for plant propagation; however, several plant species lack information about the kind of dormancy the seeds have or inaccurate reports are passed on without an in-depth investigation. We…

View details →